Kidswell Bio Corporation [4584.T]
TOKYO, Jul 01 (Pulse News Wire) – Kidswell Bio Corporation (4584.T) reported the monthly exercise status of its fourth series of unsecured convertible bonds with attached warrant rights and the 23rd issuance of warrant rights for June 2026. For the fourth series of unsecured convertible bonds, there was no delivery of shares during the month, resulting in a total exercise amount of ¥0.
As of the end of May, the remaining unused balance was ¥125 million, which decreased to ¥125 million by the end of June. There were no significant changes in the exercise status during the month. Regarding the 23rd issuance of warrant rights, no warrants were exercised during the month.
The number of outstanding warrants remained unchanged at 13,746 (equivalent to 1,374,600 shares) at the beginning of June and ended the month at 13,746 (also equivalent to 1,374,600 shares). No notable events occurred concerning the exercise status during the reporting period. The company adhered to the exercise limitations set forth by the Tokyo Stock Exchange's Securities Listing Regulations Article 434 and the Japan Securities Dealers Association's Rules Governing the Handling of Third-Party Allotments, maintaining a zero exercise rate based on the total number of outstanding shares and the total number of allotment shares.
🟢 Confidence: High AI-translated content.